- Home
- CADL vs GHI Comparison
CADL vs GHI Comparison
Compare CADL & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- GHI
- Stock Information
- Founded
- CADL 1999
- GHI 1998
- Country
- CADL United States
- GHI United States
- Employees
- CADL N/A
- GHI N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- GHI Finance: Consumer Services
- Sector
- CADL Health Care
- GHI Finance
- Exchange
- CADL Nasdaq
- GHI Nasdaq
- Market Cap
- CADL 234.8M
- GHI 264.1M
- IPO Year
- CADL 2021
- GHI N/A
- Fundamental
- Price
- CADL $4.81
- GHI $11.65
- Analyst Decision
- CADL Strong Buy
- GHI Strong Buy
- Analyst Count
- CADL 4
- GHI 4
- Target Price
- CADL $21.00
- GHI $16.00
- AVG Volume (30 Days)
- CADL 843.6K
- GHI 40.2K
- Earning Date
- CADL 05-20-2025
- GHI 05-07-2025
- Dividend Yield
- CADL N/A
- GHI 12.81%
- EPS Growth
- CADL N/A
- GHI N/A
- EPS
- CADL N/A
- GHI 0.45
- Revenue
- CADL N/A
- GHI $34,065,322.00
- Revenue This Year
- CADL N/A
- GHI $232.85
- Revenue Next Year
- CADL N/A
- GHI N/A
- P/E Ratio
- CADL N/A
- GHI $25.80
- Revenue Growth
- CADL N/A
- GHI N/A
- 52 Week Low
- CADL $3.79
- GHI $10.12
- 52 Week High
- CADL $14.60
- GHI $15.80
- Technical
- Relative Strength Index (RSI)
- CADL 42.39
- GHI 48.13
- Support Level
- CADL $4.34
- GHI $11.27
- Resistance Level
- CADL $5.34
- GHI $12.70
- Average True Range (ATR)
- CADL 0.33
- GHI 0.48
- MACD
- CADL 0.10
- GHI 0.01
- Stochastic Oscillator
- CADL 47.11
- GHI 27.24
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.